Literature DB >> 6213593

Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.

S W Newsom, J Matthews, M Amphlett, R E Warren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213593     DOI: 10.1093/jac/10.1.25

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

1.  In vitro activity of norfloxacin against Mycoplasma hominis and Ureaplasma urealyticum.

Authors:  C Simon; U Lindner
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

2.  In vitro activity of WIN 49375 compared with those of other antibiotics in isolates from cancer patients.

Authors:  I Garcia; G P Bodey; V Fainstein; D H Ho; B LeBlanc
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

3.  Antibacterial activity of norfloxacin against bacterial isolates from the urinary tract.

Authors:  S M Qadri; S Johnson
Journal:  J Natl Med Assoc       Date:  1989-04       Impact factor: 1.798

4.  In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors:  J D Gay; D R DeYoung; G D Roberts
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

Review 5.  Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  B Holmes; R N Brogden; D M Richards
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

6.  Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage.

Authors:  M Eandi; I Viano; F Di Nola; L Leone; E Genazzani
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

7.  Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.

Authors:  H L Muytjens; J van der Ros-van de Repe; G van Veldhuizen
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

8.  Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.

Authors:  K R Forward; G K Harding; G J Gray; B A Urias; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

Authors:  R Wise; J M Andrews; L J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.